Allergic Reactions at Enzyme Replacement Therapy in Children with Mucopolysaccharidosis Type II

Allergic Reactions at Enzyme Replacement Therapy in Children with Mucopolysaccharidosis Type II

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is rare hereditary disease caused by changes in the IDS gene and associated deficiency of lysosomal enzyme iduronate-2-sulfatase (I2S). The main treatment scheme for children with MPS II is enzyme replacement therapy (ERT) with recombinant huma...

Full description

Bibliographic Details
Main Authors: Julia G. Levina, Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Elena A. Vishneva, Natalia V. Zhurkova, Kamilla E. Efendieva, Anna A. Alekseeva, Vera G. Kalugina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2021-12-01
Series:Вопросы современной педиатрии
Subjects:
мукополисахаридоз, тип ii
ферментозаместительная терапия
идурсульфаза
идурсульфаза бета
инфузионные реакции
анафилаксия
Online Access:https://vsp.spr-journal.ru/jour/article/view/2782

Internet

https://vsp.spr-journal.ru/jour/article/view/2782

Similar Items